Detalhe da pesquisa
1.
Elevated 20-HETE in metabolic syndrome regulates arterial stiffness and systolic hypertension via MMP12 activation.
J Mol Cell Cardiol
; 117: 88-99, 2018 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29428638
2.
Harmonizing lipidomics: NIST interlaboratory comparison exercise for lipidomics using SRM 1950-Metabolites in Frozen Human Plasma.
J Lipid Res
; 58(12): 2275-2288, 2017 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-28986437
3.
Elevated 20-HETE impairs coronary collateral growth in metabolic syndrome via endothelial dysfunction.
Am J Physiol Heart Circ Physiol
; 312(3): H528-H540, 2017 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28011587
4.
20-HETE-induced mitochondrial superoxide production and inflammatory phenotype in vascular smooth muscle is prevented by glucose-6-phosphate dehydrogenase inhibition.
Am J Physiol Heart Circ Physiol
; 310(9): H1107-17, 2016 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-26921441
5.
Oxidized HDL is a potent inducer of adipogenesis and causes activation of the Ang-II and 20-HETE systems in human obese females.
Prostaglandins Other Lipid Mediat
; 123: 68-77, 2016 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-27179555
6.
Angiotensin II receptor blockade or deletion of vascular endothelial ACE does not prevent vascular dysfunction and remodeling in 20-HETE-dependent hypertension.
Am J Physiol Regul Integr Comp Physiol
; 309(1): R71-8, 2015 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-25924878
7.
Androgen-induced hypertension in angiotensinogen deficient mice: role of 20-HETE and EETS.
Prostaglandins Other Lipid Mediat
; 116-117: 124-30, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-25526688
8.
Soluble epoxide hydrolase-dependent regulation of myogenic response and blood pressure.
Am J Physiol Heart Circ Physiol
; 306(8): H1146-53, 2014 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-24561863
9.
20-HETE regulates the angiogenic functions of human endothelial progenitor cells and contributes to angiogenesis in vivo.
J Pharmacol Exp Ther
; 348(3): 442-51, 2014 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-24403517
10.
Androgen-sensitive hypertension associates with upregulated vascular CYP4A12-20-HETE synthase.
J Am Soc Nephrol
; 24(8): 1288-96, 2013 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-23641057
11.
Corrigendum to "Elevated 20-HETE in metabolic syndrome regulates arterial stiffness and systolic hypertension via MMP12 activation" [J. Mol. Cell. Cardiol. 117 (2018) 88-99].
J Mol Cell Cardiol
; 121: 308, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-29625729
12.
Thromboxane A2 is a key regulator of pathogenesis during Trypanosoma cruzi infection.
J Exp Med
; 204(4): 929-40, 2007 Apr 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-17420269
13.
Elevated level of pro-inflammatory eicosanoids and EPC dysfunction in diabetic patients with cardiac ischemia.
Prostaglandins Other Lipid Mediat
; 100-101: 15-21, 2013 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-23291334
14.
Arachidonate 5 lipoxygenase expression in papillary thyroid carcinoma promotes invasion via MMP-9 induction.
J Cell Biochem
; 113(6): 1998-2008, 2012 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-22253131
15.
Heme oxygenase (HO-1) rescue of adipocyte dysfunction in HO-2 deficient mice via recruitment of epoxyeicosatrienoic acids (EETs) and adiponectin.
Cell Physiol Biochem
; 29(1-2): 99-110, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22415079
16.
High potassium intake enhances the inhibitory effect of 11,12-EET on ENaC.
J Am Soc Nephrol
; 21(10): 1667-77, 2010 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-20595684
17.
20-hydroxy-5,8,11,14-eicosatetraenoic acid mediates endothelial dysfunction via IkappaB kinase-dependent endothelial nitric-oxide synthase uncoupling.
J Pharmacol Exp Ther
; 332(1): 57-65, 2010 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-19841472
18.
Endothelial-specific CYP4A2 overexpression leads to renal injury and hypertension via increased production of 20-HETE.
Am J Physiol Renal Physiol
; 297(4): F875-84, 2009 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-19675180
19.
EDHF function in the ductus arteriosus: evidence against involvement of epoxyeicosatrienoic acids and 12S-hydroxyeicosatetraenoic acid.
Am J Physiol Heart Circ Physiol
; 297(6): H2161-8, 2009 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-19801493
20.
Epoxyeicosatrienoic acid agonist rescues the metabolic syndrome phenotype of HO-2-null mice.
J Pharmacol Exp Ther
; 331(3): 906-16, 2009 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-19717790